Combined Tests Could Avoid Unnecessary Cystectomy, Study Finds - Takeaway - MDSpire
Feature

Combined Tests Could Avoid Unnecessary Cystectomy, Study Finds

Combining a visual inspection of the bladder—systematic endoscopic evaluation—with a blood test to check for the presence of ctDNA may accurately predict which patients with bladder cancer still have ...

Share

  • 1

    ctDNA tests combined with bladder visual inspection improve cancer detection.

  • 2

    New method achieved 95% accuracy in identifying residual cancer.

  • 3

    It may help avoid unnecessary cystectomy surgeries.

  • 4

    Previous studies indicate significant cancers were missed using standard methods.

  • 5

    Health outcomes improved for patients with negative ctDNA tests.

Original Source(s)

Combined Tests Could Avoid Unnecessary Cystectomy, Study Finds

  • by The ASCO Post Staff

  • April 7, 2026

Related Content

Analysis Shows Nearly 7% of Global Clinical Trials Are Impacted by Middle East Disruption

Oncology trials account for a substantial proportion of impacted activity, with non–small cell lung cancer representing the most affected indication, followed by breast cancer.

Perioperative Enfortumab Vedotin Plus Pembrolizumab in Cisplatin-Ineligible Bladder Cancer

As reported in The New England Journal of Medicine by Vulsteke et al, the phase III KEYNOTE-905/EV-303 trial has shown improved event-free and overall survival with the addition of perioperative enfor...

Can ctDNA Negativity Predict Metastasis-Free Survival in Muscle-Invasive Bladder Cancer?

Circulating tumor DNA (ctDNA) may be used to predict metastatic risk and identify which patients with muscle-invasive bladder cancer are more likely to benefit from a bladder-sparing treatment approac...